Three academics from UNSW Sydney have been recognised for their outstanding contributions to injury research, treatments for HIV, viral hepatitis and COVID-19, and leadership in immunology.
An international clinical trial has explored alternative approaches to second-line HIV therapy - with promising results.
Three major projects, focusing on reducing stigma, community-led models and assessment of people living with chronic hepatitis B, have received funding.
It’s estimated one in 10 people infected with SARS-CoV-2 will have lingering symptoms, but most people will improve over time.
A team from UNSW's Kirby Institute and St Vincent’s Hospital Sydney have uncovered an immune profile for long COVID, potentially paving the way for tailored treatment for those with ongoing symptoms.
One study suggests getting vaccinated halves the risk of developing long COVID.
A UNSW psychology researcher is behind neurocognitive testing recommendations that will help assess long COVID patients.
With over 139 million COVID-19 cases globally, the latest challenge for medical researchers is a post-COVID-19 syndrome referred to as 'long COVID'.